Skip to content
Screener

Inhibrx Biosciences, Inc. INBX Business Segments — Other segment expenses

Similar metrics at other companies

Gulfport Energy logo
GPORReportable Segments — Other segment expenses
$2.3M+2,833%
California Resources logo
CRCTotal Reportable Segments — Other segment expenses
$89M+45.9%
BellRing Brands logo
BRBRReportable Segment — Other segment expenses
$55.2M-12.2%
BJ's Wholesale Club Holdings, Inc. logo
BJReportable Segment — Other segment expenses
$1.18B+34.8%
Yext logo
YEXTReportable Segment — Other segment expenses
$22.14M+4.4%
Alignment Healthcare logo
ALHCReportable Segment — Other segment expenses
$21.91M-11.8%

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.3B+320%
Enterprise value$1.32B+474%

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026.

Filed
Mar 19, 2026, 4:00 PM EDT
Fiscal year
FY2025
Accession
0002007919-26-000006
Line itemYEAR ENDEDDECEMBER 31, 2025YEAR ENDEDDECEMBER 31, 2024
General and administrative expense
Merger-related68,061
Personnel14,48137,649
Other general and administrative8,81622,195
Other income (expense)(5,028)(2,476)
Other segment items(1)2,021,498
Other segment expenses(2)22
Segment and consolidated net income (loss)$(140,055)$1,687,572

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Inhibrx Biosciences, Inc.'s business segments — other segment expenses?
Inhibrx Biosciences, Inc. (INBX) reported business segments — other segment expenses of $500 in Q4 2025.
How has Inhibrx Biosciences, Inc.'s business segments — other segment expenses changed year-over-year?
Inhibrx Biosciences, Inc.'s business segments — other segment expenses decreased by 0.0% year-over-year, from $500 to $500.
What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — other segment expenses?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — other segment expenses has grown at a -96.5% compound annual growth rate (CAGR), from $1.64M to $2K.
What does business segments — other segment expenses mean?
Includes residual operating expenses that do not fall into the primary cost categories of the reportable segment. Tracking this helps ensure comprehensive coverage of all costs incurred to support the segment's business activities.

Ask your AI about Inhibrx Biosciences, Inc.'s business segments — other segment expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude